{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T16:34:10Z","timestamp":1793205250383,"version":"4.5.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Hypertension"],"published-print":{"date-parts":[[2003,1]]},"abstract":"<jats:p>It has been reported that continuous ACE inhibitor therapy does not necessarily produce a maintained decrease in plasma aldosterone levels, which may remain high or increase eventually during long-term use (aldosterone escape). We have examined the role of aldosterone escape in 45 patients with type 2 diabetes and early nephropathy treated with an ACE inhibitor for 40 weeks. With treatment, there was a 40% reduction in average urinary albumin excretion, although urinary albumin excretion in patients with aldosterone escape (18 patients) was significantly higher than that in patients without escape (27 patients). In the 18 patients with escape, spironolactone (25 mg\/d) was added to ACE inhibitor treatment in 13. After a 24-week study period, urinary albumin excretion and left ventricular mass index were significantly reduced without blood pressure change. In conclusion, the present study demonstrates that aldosterone escape is observed in 40% of patients with type 2 diabetes with early nephropathy despite the use of ACE inhibitors. Our study suggests the possibility that aldosterone blockade may represent optimal therapy for patients with early diabetic nephropathy who show aldosterone escape during ACE inhibitor treatment and who no longer show maximal antiproteinuric effects of ACE inhibition. Additional, larger, prospectively randomized, double-blind studies will be needed before adaptation of this strategy.<\/jats:p>","DOI":"10.1161\/01.hyp.0000044937.95080.e9","type":"journal-article","created":{"date-parts":[[2003,1,3]],"date-time":"2003-01-03T20:33:26Z","timestamp":1041626006000},"page":"64-68","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":372,"title":["Effectiveness of Aldosterone Blockade in Patients With Diabetic Nephropathy"],"prefix":"10.1161","volume":"41","author":[{"given":"Atsuhisa","family":"Sato","sequence":"first","affiliation":[{"name":"From the Department of Internal Medicine, Mito Red Cross Hospital (A.S.), Ibaraki; the Department of Internal Medicine, Keio University (K.H., T.S.), Tokyo; and the Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women\u2019s Medical University (M.N.), Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Hayashi","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine, Mito Red Cross Hospital (A.S.), Ibaraki; the Department of Internal Medicine, Keio University (K.H., T.S.), Tokyo; and the Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women\u2019s Medical University (M.N.), Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhide","family":"Naruse","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine, Mito Red Cross Hospital (A.S.), Ibaraki; the Department of Internal Medicine, Keio University (K.H., T.S.), Tokyo; and the Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women\u2019s Medical University (M.N.), Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Saruta","sequence":"additional","affiliation":[{"name":"From the Department of Internal Medicine, Mito Red Cross Hospital (A.S.), Ibaraki; the Department of Internal Medicine, Keio University (K.H., T.S.), Tokyo; and the Department of Medicine, Institute of Clinical Endocrinology, Tokyo Women\u2019s Medical University (M.N.), Tokyo, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI104436"},{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.3109\/10641969709083193"},{"key":"e_1_3_2_3_2","first-page":"893","volume":"120","year":"1992","unstructured":"Brilla CG, Weber KT. Mineralocorticoid excess, dietary sodium and myocardial fibrosis. J Lab Clin Med. 1992; 120: 893\u2013901.","journal-title":"J Lab Clin Med"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909023411001"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.23.25"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1177\/147323000102900103"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.24.99"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.22.17"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200105000-00001"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.141.10.7711"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/hyp.35.5.1078"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/circ.100.10.1134"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.22069"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1997.00440420033005"},{"key":"e_1_3_2_15_2","first-page":"17:151","volume":"1999","year":"1999","unstructured":"Guidelines Subcommittee. World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens. 1999; 1999: 17:151\u2013183.","journal-title":"J Hypertens"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1987.00370050135022"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198312223092503"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.2007.S85"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.58.6.1072"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.55.4.613"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(82)90390-3"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.0910457"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1071-9164(96)80009-1"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1993.tb03901.x"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01714-4"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01237-2"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200109203451215"},{"key":"e_1_3_2_28_2","first-page":"91.","volume":"21","year":"2000","unstructured":"Arutyunov G, Chernyavskaya T, Korsunskaya M, Rylova A. Study of the efficacy and safety of RAAS long-term complete blockade in type II diabetic patients with MAU and essential hypertension. Eur Heart J. 2000; 21: 91.Abstract.","journal-title":"Eur Heart J"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00055.x"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.137.10.8828470"}],"container-title":["Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.HYP.0000044937.95080.E9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T16:42:17Z","timestamp":1715532137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.HYP.0000044937.95080.E9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["10.1161\/01.HYP.0000044937.95080.E9"],"URL":"https:\/\/doi.org\/10.1161\/01.hyp.0000044937.95080.e9","relation":{},"ISSN":["0194-911X","1524-4563"],"issn-type":[{"value":"0194-911X","type":"print"},{"value":"1524-4563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1]]},"assertion":[{"value":"2002-06-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-10-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-11-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}